Skip to content

A study to test how a new long-acting insulin works in the body of patients with type 2 diabetes during exercise and prolonged fasting.

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-505012-38-00
Acronym
NN1436-7615
Enrollment
30
Registered
2024-02-12
Start date
2024-02-21
Completion date
2025-04-14
Last updated
2025-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

None listed

Sponsors

Novo Nordisk A/S
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Austria

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026